Does ephedrine promote weight loss in low-energy-adapted obese women?
Does ephedrine promote weight loss in low-energy-adapted obese women?
Pasquali et al., 1987 | Int J Obes | Rct
Citation
Pasquali R, Cesari M P, ... Labo G. Does ephedrine promote weight loss in low-energy-adapted obese women?. Int J Obes. 1987;11(2):163-8
Abstract
A double-blind cross-over randomized study was performed in 10 selected adult overweight and obese (body mass index greater than 27) women who had been adapted to low-energy intake for a long period of time and who had shown difficulty in losing weight with conventional hypocaloric treatment. Combined with diet therapy (1000-1400 kcal/day), l(-)ephedrine hydrochloride (50 mg three times a day per os) or placebo were administered daily before each meal, after a period of stabilization with diet only for 1 month. Each pharmacological treatment lasted for 2 months. Weight loss was significantly (P less than 0.05) greater during the ephedrine period (2.41 +/- 0.61 kg) than during the placebo period (0.64 +/- 0.50 kg). None of the patients presented clinically important side-effects. These preliminary results seem to suggest a possible role for a thermogenic compound such as ephedrine in promoting weight loss in low-energy-adapted obese women.
Key Findings
These preliminary results seem to suggest a possible role for a thermogenic compound such as ephedrine in promoting weight loss in low-energy-adapted obese women.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Adult
- Body Weight
- Clinical Trials as Topic
- Diet, Reducing
- Double-Blind Method
- Energy Metabolism
- Ephedrine
- Female
- Humans
- Middle Aged
- Obesity
- Random Allocation
Evidence Classification
- Level: Rct
- Publication Types: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Vertical: ephedra
Provenance
- PMID: 3301709
- DOI: (not available)
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09